Gini Fleming to Signal Transduction
This is a "connection" page, showing publications Gini Fleming has written about Signal Transduction.
Connection Strength
0.034
-
Myasthenia gravis induced by avelumab. Immunotherapy. 2019 10; 11(14):1181-1185.
Score: 0.020
-
A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia. Gynecol Oncol. 2015 May; 137(2):216-22.
Score: 0.015